CG
GBT

Cutler Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Cutler Group’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-9,300
Closed -$73K – 5662
2022
Q3 		$73K Buy
+9,300
New +$513K 0.01% 1623
2022
Q1 		– Sell
-8,200
Closed -$4K – 6383
2021
Q4 		$4K Buy
+8,200
New +$254K ﹤0.01% 4440
2021
Q2 		– Sell
-8,100
Closed -$3K – 6639
2021
Q1 		$3K Buy
+8,100
New +$372K ﹤0.01% 4820
2020
Q4 		– Sell
-2,100
Closed -$8K – 5731
2020
Q3 		$8K Sell
2,100
-5,300
-72% -$337K ﹤0.01% 3203
2020
Q2 		$26K Sell
7,400
-200
-3% -$13.7K ﹤0.01% 2213
2020
Q1 		$19K Sell
7,600
-10,600
-58% -$710K ﹤0.01% 2355
2019
Q4 		$230K Buy
18,200
+16,100
+767% +$954K 0.01% 759
2019
Q3 		$15K Sell
2,100
-18,200
-90% -$948K ﹤0.01% 2388
2019
Q2 		$32K Buy
20,300
+17,600
+652% +$1.01M ﹤0.01% 1881
2019
Q1 		$24K Sell
2,700
-12,800
-83% -$629K ﹤0.01% 1924
2018
Q4 		$18K Sell
15,500
-5,100
-25% -$191K ﹤0.01% 2194
2018
Q3 		$33K Buy
20,600
+2,900
+16% +$128K ﹤0.01% 1897
2018
Q2 		$80K Sell
17,700
-5,400
-23% -$246K 0.01% 1301
2018
Q1 		$156K Buy
23,100
+3,900
+20% +$218K 0.01% 945
2017
Q4 		$129K Buy
19,200
+16,100
+519% +$601K 0.01% 1227
2017
Q3 		$20K Sell
3,100
-20,200
-87% -$568K ﹤0.01% 3158
2017
Q2 		$37K Sell
23,300
-31,400
-57% -$934K ﹤0.01% 2794
2017
Q1 		$410K Buy
54,700
+39,500
+260% +$995K 0.02% 737
2016
Q4 		$14K Sell
15,200
-26,800
-64% -$471K ﹤0.01% 3870
2016
Q3 		$152K Buy
42,000
+32,100
+324% +$612K 0.01% 1451
2016
Q2 		$7K Buy
9,900
+2,800
+39% +$56.5K ﹤0.01% 4645
2016
Q1 		$29K Buy
+7,100
New +$126K ﹤0.01% 2894

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cutler Group's GBT Position: Q4 2022 in Review

Cutler Group sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 800 shares — an estimated $54K sold.

Cutler Group first reported a position in GBT in Q1 2016 and held it in 24 quarters. The position peaked at $1.05M in Q4 2017. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Cutler Group reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Cutler Group sold 800 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $54K.
  • Cutler Group first reported a position in Global Blood Therapeutics, Inc. in Q1 2016 and held it in 24 quarters.
  • Cutler Group's Global Blood Therapeutics, Inc. position peaked at $1.05M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.